ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 238 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $117,000 | -28.7% | 16,668 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $164,000 | -20.0% | 16,668 | -10.9% | 0.00% | -20.0% |
| Q3 2019 | $205,000 | -11.6% | 18,705 | -6.4% | 0.01% | 0.0% |
| Q2 2019 | $232,000 | +16.6% | 19,989 | -4.2% | 0.01% | 0.0% |
| Q1 2019 | $199,000 | -2.9% | 20,873 | -1.9% | 0.01% | -16.7% |
| Q4 2018 | $205,000 | -32.8% | 21,281 | -0.5% | 0.01% | -14.3% |
| Q3 2018 | $305,000 | +15.1% | 21,381 | -3.1% | 0.01% | 0.0% |
| Q2 2018 | $265,000 | -3.3% | 22,054 | -0.5% | 0.01% | 0.0% |
| Q1 2018 | $274,000 | -15.4% | 22,154 | -0.4% | 0.01% | -12.5% |
| Q4 2017 | $324,000 | -0.3% | 22,254 | -2.4% | 0.01% | 0.0% |
| Q3 2017 | $325,000 | +11.3% | 22,809 | -0.4% | 0.01% | 0.0% |
| Q2 2017 | $292,000 | -0.3% | 22,909 | -0.9% | 0.01% | 0.0% |
| Q1 2017 | $293,000 | +24.7% | 23,112 | +0.5% | 0.01% | +33.3% |
| Q4 2016 | $235,000 | -21.1% | 23,003 | +1.5% | 0.01% | -25.0% |
| Q3 2016 | $298,000 | +3.5% | 22,656 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $288,000 | -14.5% | 22,656 | -11.2% | 0.01% | -20.0% |
| Q1 2016 | $337,000 | -11.5% | 25,525 | +3.0% | 0.01% | -9.1% |
| Q4 2015 | $381,000 | +16.9% | 24,778 | -5.8% | 0.01% | 0.0% |
| Q3 2015 | $326,000 | -0.9% | 26,295 | +9.5% | 0.01% | +10.0% |
| Q2 2015 | $329,000 | +13.8% | 24,014 | -0.7% | 0.01% | +25.0% |
| Q1 2015 | $289,000 | -4.6% | 24,185 | +2.1% | 0.01% | -11.1% |
| Q4 2014 | $303,000 | -5.6% | 23,689 | -1.0% | 0.01% | -18.2% |
| Q3 2014 | $321,000 | -10.6% | 23,917 | +6.9% | 0.01% | -8.3% |
| Q2 2014 | $359,000 | -13.3% | 22,381 | -2.5% | 0.01% | -20.0% |
| Q1 2014 | $414,000 | +16.6% | 22,951 | 0.0% | 0.02% | +15.4% |
| Q4 2013 | $355,000 | +1.1% | 22,951 | -2.7% | 0.01% | -7.1% |
| Q3 2013 | $351,000 | +2.0% | 23,595 | -11.2% | 0.01% | 0.0% |
| Q2 2013 | $344,000 | -2.3% | 26,561 | +2.7% | 0.01% | 0.0% |
| Q1 2013 | $352,000 | +44.3% | 25,875 | 0.0% | 0.01% | +27.3% |
| Q4 2012 | $244,000 | -24.0% | 25,875 | 0.0% | 0.01% | -21.4% |
| Q3 2012 | $321,000 | +2.9% | 25,875 | -9.3% | 0.01% | -6.7% |
| Q2 2012 | $312,000 | -34.6% | 28,539 | -0.6% | 0.02% | -31.8% |
| Q1 2012 | $477,000 | -12.6% | 28,721 | -0.3% | 0.02% | -21.4% |
| Q4 2011 | $546,000 | +7.9% | 28,821 | +2.7% | 0.03% | -3.4% |
| Q3 2011 | $506,000 | – | 28,070 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |